BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9820995)

  • 21. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
    van den Berg MP; Tjeerdsma G; Jan de Kam P; Boomsma F; Crijns HJ; van Veldhuisen DJ
    Eur J Heart Fail; 2002 Jun; 4(3):255-62. PubMed ID: 12034149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure.
    van Veldhuisen DJ; Boomsma F; de Kam PJ; Man in't Veld AJ; Crijns HJ; Hampton JR; Lie KI
    Eur Heart J; 1998 May; 19(5):753-60. PubMed ID: 9717009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms.
    Rouleau JL; Kortas C; Bichet D; de Champlain J
    Am Heart J; 1988 Sep; 116(3):746-57. PubMed ID: 2970771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators.
    Benedict CR; Weiner DH; Johnstone DE; Bourassa MG; Ghali JK; Nicklas J; Kirlin P; Greenberg B; Quinones MA; Yusuf S
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):146A-153A. PubMed ID: 8376686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic peptide response is blunted in patients with acute myocardial infarction and mild left ventricular dysfunction.
    Derchi G; Bellone P; Tommasini G; Biorci ML; Randazzo M; Primarolo P; Vecchio C
    Cardiology; 1994; 84(2):79-88. PubMed ID: 8174145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.
    Pacher R; Globits S; Bergler-Klein J; Teufelsbauer H; Wutte M; Baumgartner W; Ogris E; Glogar D
    Eur Heart J; 1993 Feb; 14(2):273-8. PubMed ID: 8449205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of neurohumoral systems following acute myocardial infarction.
    Rouleau JL; Moyé LA; de Champlain J; Klein M; Bichet D; Packer M; Dagenais G; Sussex B; Arnold JM; Sestier F
    Am J Cardiol; 1991 Nov; 68(14):80D-86D. PubMed ID: 1684082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.
    Groenning BA; Nilsson JC; Sondergaard L; Kjaer A; Larsson HB; Hildebrandt PR
    Eur J Heart Fail; 2001 Dec; 3(6):699-708. PubMed ID: 11738222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of enalapril on plasma atrial natriuretic peptide in late recovery phase of acute myocardial infarction.
    Hirvonen T; Remes J; Mustonen J; Tikkanen I; Tenhunen M; Pyörälä K
    Ann Med; 1991 Aug; 23(3):271-5. PubMed ID: 1834093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction.
    Rademaker MT; Cameron VA; Charles CJ; Espiner EA; Nicholls MG; Pemberton CJ; Richards AM
    Am J Physiol Heart Circ Physiol; 2000 Mar; 278(3):H731-40. PubMed ID: 10710340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
    St John Sutton M; Pfeffer MA; Plappert T; Rouleau JL; Moyé LA; Dagenais GR; Lamas GA; Klein M; Sussex B; Goldman S
    Circulation; 1994 Jan; 89(1):68-75. PubMed ID: 8281697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.
    White M; Rouleau JL; Hall C; Arnold M; Harel F; Sirois P; Greaves S; Solomon S; Ajani U; Glynn R; Hennekens C; Pfeffer M
    Am Heart J; 2001 Dec; 142(6):1056-64. PubMed ID: 11717612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
    Hillege HL; Girbes AR; de Kam PJ; Boomsma F; de Zeeuw D; Charlesworth A; Hampton JR; van Veldhuisen DJ
    Circulation; 2000 Jul; 102(2):203-10. PubMed ID: 10889132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short- and long-term neurohormonal activation following acute myocardial infarction.
    Sigurdsson A; Held P; Swedberg K
    Am Heart J; 1993 Nov; 126(5):1068-76. PubMed ID: 8237747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure.
    Tsutamoto T; Sakai H; Tanaka T; Fujii M; Yamamoto T; Wada A; Ohnishi M; Horie M
    Circ J; 2007 Jun; 71(6):915-21. PubMed ID: 17526990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
    Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.